P3 Health Partners
PIII
76 hedge funds and large institutions have $229M invested in P3 Health Partners in 2021 Q2 according to their latest regulatory filings, with 76 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.45% more ownership
Funds ownership: 0% → 1.45% (+1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
LH Capital Markets
New York
|
+$29.4M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$10.8M |
| 3 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$8.9M |
| 4 |
Millennium Management
New York
|
+$7.5M |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$7.34M |
Top Sellers
PIII Hedge Fund Activity: Q2 2021 in Review
76 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q2 2021, worth a combined $229M.
Buyers outnumbered sellers: 76 funds opened new PIII positions and 0 closed out — a net gain of 76 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was LH Capital Markets, opening a new position worth an estimated $29.4M.
- 76 institutional investors held P3 Health Partners (PIII) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $229M of P3 Health Partners stock for Q2 2021.
- 76 funds opened new P3 Health Partners positions in Q2 2021 and 0 closed out, a net change of +76 holders.
- The largest P3 Health Partners buyer in Q2 2021 was LH Capital Markets, an estimated $29.4M added.
Based on aggregated 13F filings for Q2 2021.